Journal for ImmunoTherapy of Cancer (Nov 2023)
1406 A novel PTK7-directed antibody-drug conjugate (ADC) PRO1107 demonstrated broad antitumor activity with a promising safety profile in preclinical models
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)